Migraine Prevention Using ActiPatch
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Migraine
Related studies linked through entity extraction aliases.
A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks
- Status
- WITHDRAWN
- Phase
- PHASE4
Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
- Status
- COMPLETED
- Phase
- NA
Infants Colics : Towards a Migrainous Origin ?
- Status
- UNKNOWN
- Phase
- N/A
Melatonin for Adolescent Migraine Prevention Study
- Status
- TERMINATED
- Phase
- PHASE2
Energy for the Brain
- Status
- COMPLETED
- Phase
- NA
Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
- Status
- UNKNOWN
- Phase
- NA
Migraine and CVD Risk in Women
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Very Low Calories Ketogenic Diet in Migraine.
- Status
- COMPLETED
- Phase
- NA
Status Migrainosus - Differentiating Between Responders and Non-responders
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
The Effects of Caffeine Withdrawal on Migraine
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Structural and Molecular Neuroplasticity in Migraine
- Status
- COMPLETED
- Phase
- NA
Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
- Status
- TERMINATED
- Phase
- NA
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
- Status
- COMPLETED
- Phase
- PHASE2